Common use of BY AND BETWEEN Clause in Contracts

BY AND BETWEEN. Pxxxxx Operations Pty Ltd. Omnicare CR, Inc. By: /s/ Mxxxxxx Xxxxxxxx By: /s/ Dxxx Xxxxx Name: Mxxxxxx Xxxxxxxx Name: Dxxx Xxxxx Title: Managing Director & CEO Title: CEO Dated: 4-oct-06 Dated: 10/10/06 **** Certain confidential information contained in this document, marked with four asterisks, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. Exhibit C to the Clinical Services Master Agreement between Pxxxxx Operations Pty Ltd. and Omnicare CR, Inc., dated 24-08-05. THIS EXHIBIT C is entered into this 24th day of August, 2005 (“Effective Date”), by and between Pxxxxx Operations Pty Ltd. (hereinafter “Sponsor”) and Omnicare CR, Inc. (hereinafter “Omnicare CR”).

BY AND BETWEEN. Pxxxxx Xxxxxx Operations Pty Ltd. Omnicare CR, Inc. By: /s/ Mxxxxxx Xxxxxxxx Xxxxx Xxxxxxx By: /s/ Dxxx Xxxx Xxxxx Name: Mxxxxxx Xxxxxxxx Xxxxx Xxxxxxx Name: Dxxx Xxxx Xxxxx Title: Managing Director & CEO General Manager Title: CEO DatedChief Executive Officer Date: 4-oct-06 Dated7/3/07 Date: 10/10/06 27/2/07 **** Certain confidential information contained in this document, marked with four asterisks, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 24b-2 of the Securities Exchange Act of 19331934, as amended. Exhibit C G to the Clinical Services Master Agreement between Pxxxxx Xxxxxx Operations Pty Ltd. and Omnicare CR, Inc., dated 24-08-05June 1, 2005. THIS EXHIBIT C G is entered into this 24th 12 th day of August, 2005 (“Effective Date”)May 2006, by and between Pxxxxx Xxxxxx Operations Pty Ltd. (hereinafter “Sponsor”) and Omnicare CR, Inc. (hereinafter “Omnicare CR”).

BY AND BETWEEN. Pxxxxx Operations Pty Ltd. Omnicare CR, Inc. By: /s/ Mxxxxxx Xxxxxxxx By: /s/ Dxxx Xxxxx Name: Mxxxxxx Xxxxxxxx Name: Dxxx Xxxxx Title: Managing Director & CEO Title: CEO Dated: 4-oct-06 Oct-06 Dated: 10/10/06 **** Certain confidential information contained in this document, marked with four asterisks, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. Change Order #05 to Exhibit C A to the Clinical Services Master Agreement between Pxxxxx Operations Pty Ltd. and Omnicare CR, Inc., dated 24-08-0524th August 2005. THIS EXHIBIT C CHANGE ORDER is entered into this 24th day 18th Day of AugustJanuary, 2005 2007 (“Effective Date”), by and between Pxxxxx Operations Pty Ltd. (hereinafter “Sponsor”) and Omnicare CR, Inc. (hereinafter “Omnicare CR”).

BY AND BETWEEN. Pxxxxx Operations Pty Ltd. Omnicare CR, Inc. By: /s/ Mxxxxxx Xxxxxxxx Pxxxx Xxxxxxx By: /s/ Dxxx Xxxxx Name: Mxxxxxx Xxxxxxxx Pxxxx Xxxxxxx Name: Dxxx Xxxxx Title: Managing Director & CEO General Manager Title: CEO DatedChief Executive Officer Date: 4-oct-06 Dated7/3/07 Date: 10/10/06 27/2/07 **** Certain confidential information contained in this document, marked with four asterisks, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. Exhibit C G to the Clinical Services Master Agreement between Pxxxxx Operations Pty Ltd. and Omnicare CR, Inc., dated 24-08-05June 1, 2005. THIS EXHIBIT C G is entered into this 24th 12th day of August, 2005 (“Effective Date”)May 2006, by and between Pxxxxx Operations Pty Ltd. (hereinafter “Sponsor”) and Omnicare CR, Inc. (hereinafter “Omnicare CR”).

BY AND BETWEEN. Pxxxxx Xxxxxx Operations Pty Ltd. Omnicare CR, Inc. By: /s/ Mxxxxxx Xxxxxxxx Xxxxx Xxxxxxx By: /s/ Dxxx Xxxx Xxxxx Name: Mxxxxxx Xxxxxxxx Xxxxx Xxxxxxx Chief Scientific Officer and Vice President, Name: Dxxx Xxxx Xxxxx Title: Managing Director & CEO Title: CEO DatedTitle: 4-oct-06 DatedResearch & Development Date: 10/10/06 17 October 2006 Date: 10/24/06 [SEAL] **** Certain confidential information contained in this document, marked with four asterisks, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. Change Order #01 to Exhibit C I to the Clinical Services Master Agreement between Pxxxxx Xxxxxx Operations Pty Ltd. and Omnicare CR, Inc., dated 24-08-051st June 2005. THIS EXHIBIT C CHANGE ORDER is entered into this 24th 20th day of August, 2005 November 2006 (“Effective Date”), by and between Pxxxxx Xxxxxx Operations Pty Ltd. (hereinafter “Sponsor”) and Omnicare CR, Inc. (hereinafter “Omnicare CR”).

BY AND BETWEEN. Pxxxxx Xxxxxx Operations Pty Ltd. Omnicare CR, Inc. By: /s/ Mxxxxxx Xxxxxxxx Xxxxx Xxxxxxx By: /s/ Dxxx Xxxxx X. Xxxxx Name: Mxxxxxx Xxxxxxxx Xxxxx Xxxxxxx Name: Dxxx Xxxxx X. Xxxxx Title: Managing Director & CEO Director, Drug Development Title: CEO Senior Vice President Marketing & Business Development Dated: 4-oct-06 October 3, 2005 Dated: 10/10/06 10/24/05 **** Certain confidential information contained in this document, marked with four asterisks, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 24b-2 of the Securities Exchange Act of 19331934, as amended. Change Order #02 to Exhibit C A to the Clinical Services Master Agreement between Pxxxxx Xxxxxx Operations Pty Ltd. and Omnicare CR, Inc., dated 24-08-0524th August 2005. THIS EXHIBIT C CHANGE ORDER is entered into this 24th day of AugustOctober, 2005 (“Effective Date”), by and between Pxxxxx Xxxxxx Operations Pty Ltd. (hereinafter “Sponsor”) and Omnicare CR, Inc. (hereinafter “Omnicare CR”).

BY AND BETWEEN. Pxxxxx Xxxxxx Operations Pty Ltd. Omnicare CR, Inc. By: /s/ Mxxxxxx Xxxxxxxx Xxxxx Xxxxxxx By: /s/ Dxxx Xxxx Xxxxx Name: Mxxxxxx Xxxxxxxx Xxxxx Xxxxxxx Name: Dxxx Xxxx Xxxxx Title: Managing Director & CEO General Manager Title: CEO DatedChief Executive Officer Date: 4-oct-06 Dated7/3/07 Date: 10/10/06 27/2/07 **** Certain confidential information contained in this document, marked with four asterisks, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. Exhibit C G to the Clinical Services Master Agreement between Pxxxxx Xxxxxx Operations Pty Ltd. and Omnicare CR, Inc., dated 24-08-05June 1, 2005. THIS EXHIBIT C G is entered into this 24th 12 th day of August, 2005 (“Effective Date”)May 2006, by and between Pxxxxx Xxxxxx Operations Pty Ltd. (hereinafter “Sponsor”) and Omnicare CR, Inc. (hereinafter “Omnicare CR”).

BY AND BETWEEN. Pxxxxx Operations Pty Ltd. Omnicare CR, Inc. By: /s/ Mxxxxxx Xxxxxxxx Pxxxx Xxxxxxx By: /s/ Dxxx Kxxxx X. Xxxxx Name: Mxxxxxx Xxxxxxxx Pxxxx Xxxxxxx Name: Dxxx Kxxxx X. Xxxxx Title: Managing Director & CEO Director, Drug Development Title: CEO Senior Vice President Marketing & Business Development Dated: 4-oct-06 October 3, 2005 Dated: 10/10/06 10/24/05 **** Certain confidential information contained in this document, marked with four asterisks, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. Change Order #02 to Exhibit C A to the Clinical Services Master Agreement between Pxxxxx Operations Pty Ltd. and Omnicare CR, Inc., dated 24-08-0524th August 2005. THIS EXHIBIT C CHANGE ORDER is entered into this 24th day of AugustOctober, 2005 (“Effective Date”), by and between Pxxxxx Operations Pty Ltd. (hereinafter “Sponsor”) and Omnicare CR, Inc. (hereinafter “Omnicare CR”).

BY AND BETWEEN. Pxxxxx Xxxxxx Operations Pty Ltd. Omnicare CR, Inc. By: /s/ Mxxxxxx Xxxxxxxx Xxxxx Xxxxxxx By: /s/ Dxxx Xxxx Xxxxx Name: Mxxxxxx Xxxxxxxx Xxxxx Xxxxxxx Chief Scientific Officer and Vice President, Name: Dxxx Xxxx Xxxxx Title: Managing Director & CEO Title: CEO DatedTitle: 4-oct-06 DatedResearch & Development Date: 10/10/06 17 October 2006 Date: 10/24/06 [SEAL] **** Certain confidential information contained in this document, marked with four asterisks, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 24b-2 of the Securities Exchange Act of 19331934, as amended. Change Order #01 to Exhibit C I to the Clinical Services Master Agreement between Pxxxxx Xxxxxx Operations Pty Ltd. and Omnicare CR, Inc., dated 24-08-051st June 2005. THIS EXHIBIT C CHANGE ORDER is entered into this 24th 20th day of August, 2005 November 2006 (“Effective Date”), by and between Pxxxxx Xxxxxx Operations Pty Ltd. (hereinafter “Sponsor”) and Omnicare CR, Inc. (hereinafter “Omnicare CR”).